| Quarter (USD) | Dec 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 11 |
| Opened positions | 5 |
| Closed positions | 1 |
| Increased positions | 1 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 3.48 bn |
| Total shares | 34.74 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Thiel Peter | 22.63 mm | $1.71 bn |
| Access Industries | 5.06 mm | $381.15 mm |
| Gabriel Capital Management | 3.09 mm | $21.30 mm |
| OrbiMed Israel BioFund GP Limited Partnership | 1.86 mm | $3.24 mm |
| Sphera Funds Management | 1.21 mm | $1.45 mm |
| Yelin Lapidot Holdings Management | 809.72 k | $1.27 bn |
| Kestra Private Wealth Services | 31.24 k | $49.05 mm |
| Rhumbline Advisers | 27.57 k | $43.28 mm |
| HRT Financial | 13.58 k | $21.00 k |
| JPM JPMorgan Chase & Co. | 1.10 k | $1.73 mm |
